文献速递心血管US

磷酸受纳蛋白突变携带者的早期机械性改变:在症状出现前识别亚临床疾病

Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of Symptoms.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-11-18

本研究纳入281例PLN p.Arg14del突变携带者(其中139例为症状前期)及70名年龄性别匹配的对照,进行包括形变成像在内的综合超声心动图分析。症状前期携带者整体纵向应变较低、左室机械离散度较高,且31%存在心尖部收缩后缩短,后者是室性心律失常的最强超声预测因子(多变量HR 5.11)。

要点

  • 症状前期PLN p.Arg14del携带者已出现整体纵向应变降低和左室机械离散度增高。
  • 心尖部收缩后缩短见于31%症状前期携带者,而对照组无一例出现。
  • 心尖部收缩后缩短预测室性心律失常的多变量HR为5.11,阴性预测值96%。

关键影像表现/征象

  • 与对照相比,症状前期突变携带者整体纵向应变较低且左室机械离散度较高(均p<0.001)。
  • 心尖部收缩后缩短见于43例症状前期突变携带者(31%),对照组无一例出现。

诊断标准与关键数值

  • 症状前期定义:无室性心律失常史、室性早搏<500/24 h、左室射血分数≥45%。
  • 心尖部收缩后缩短预测室性心律失常的多变量风险比5.11(95%CI 1.37–19.08,p=0.015)。
  • 心尖部收缩后缩短预测室性心律失常的阴性预测值96%(95%CI 89%–98%),阳性预测值29%(95%CI 21%–40%)。

临床应用与阅片要点

  • 对PLN p.Arg14del携带者行超声心动图检查时应包括形变成像,关注整体纵向应变、左室机械离散度和心尖部收缩后缩短。
  • 症状前期携带者若心尖部形变模式正常,3年内发生室性心律失常风险低;存在心尖部收缩后缩短者风险似乎较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to explore echocardiographic characteristics of phospholamban (PLN) p.Arg14del mutation carriers to investigate whether structural and/or functional abnormalities could be identified before onset of symptoms.

BACKGROUND: Carriers of the genetic PLN p.Arg14del mutation may develop arrhythmogenic and/or dilated cardiomyopathy. Overt disease is preceded by a pre-symptomatic phase of variable length in which disease expression seems to be absent.

METHODS: PLN p.Arg14del mutation carriers with an available echocardiogram were included. Mutation carriers were classified as pre-symptomatic if they had no history of ventricular arrhythmias (VAs), a premature ventricular complex count of <500/24 h, and a left ventricular (LV) ejection fraction of ≥45%. In addition, we included 70 control subjects with similar age and sex distribution as the pre-symptomatic mutation carriers. Comprehensive echocardiographic analysis (including deformation imaging) was performed.

RESULTS: The final study population consisted of 281 PLN p.Arg14del mutation carriers, 139 of whom were classified as pre-symptomatic. In comparison to control subjects, pre-symptomatic mutation carriers had lower global longitudinal strain and higher LV mechanical dispersion (both p < 0.001). In addition, post-systolic shortening (PSS) in the LV apex was observed in 43 pre-symptomatic mutation carriers (31%) and in none of the control subjects. During a median follow-up of 3.2 years (interquartile range: 2.1 to 5.6 years) in 104 pre-symptomatic mutation carriers, nonsustained VA occurred in 13 (13%). Presence of apical PSS was the strongest echocardiographic predictor of VA (multivariable hazards ratio: 5.11; 95% confidence interval [CI]: 1.37 to 19.08; p = 0.015), which resulted in a negative predictive value of 96% (95% CI: 89% to 98%) and a positive predictive value of 29% (95% CI: 21% to 40%).

CONCLUSIONS: Global and regional LV mechanical alterations in PLN p.Arg14del mutation carriers precede arrhythmic symptoms and overt structural disease. Pre-symptomatic mutation carriers with normal deformation patterns in the apex are at low risk of developing VA within 3 years, whereas mutation carriers with apical PSS appear to be at higher risk.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Taha K, Te Rijdt WP, Verstraelen TE, et al. Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of Symptoms. JACC Cardiovasc Imaging. 2020. PMID: 33221241. doi:10.1016/j.jcmg.2020.09.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。